- •
Eosinophilic lung diseases may present as eosinophilic pneumonia with chronic or acute onset, or as the more transient Löffler syndrome.
- •
The diagnosis of eosinophilic pneumonia is based on both characteristic clinical-imaging features and the demonstration of alveolar eosinophilia of at least 25% eosinophils at bronchoalveolar lavage.
- •
Peripheral blood eosinophilia is present in most eosinophilic lung disorders, but can be absent at presentation in idiopathic acute eosinophilic pneumonia and in
Eosinophilic Lung Diseases
Section snippets
Key points
Definition
Eosinophilic lung diseases are a group of diffuse parenchymal lung diseases1, 2 characterized by the prominent infiltration of the lung interstitium and the alveolar spaces by polymorphonuclear eosinophils, with conservation of the lung architecture. As a corollary, a common denominator of eosinophilic lung diseases is represented by a dramatic response to systemic corticosteroid therapy and healing without any sequelae in most cases, despite frequent impressive impairment of lung function at
Recruitment of Eosinophils to the Lung
Blood and tissue eosinophilia have long been identified as major players in immunity against parasites and in the pathogenesis of allergic diseases.6 Following differentiation of precursor cells in the bone marrow under the action of several cytokines, including interleukin (IL)-5, IL-3, and granulocyte macrophage colony-stimulating factor (GM-CSF),7, 8, 9 eosinophils are recruited in the blood and tissue, including the lung in response to circulating IL-5, eotaxins, and the C-C chemokine
Idiopathic chronic eosinophilic pneumonia
First characterized by Carrington and colleagues,19 idiopathic chronic eosinophilic pneumonia (ICEP) is characterized by the onset over a few weeks of cough, dyspnea, malaise, and weight loss, with diffuse pulmonary infiltrates.
Idiopathic acute eosinophilic pneumonia
IAEP, first described by Badesch and colleagues48 and later individualized by Allen and colleagues,49 is both the most dramatic and the most frequently misdiagnosed of eosinophilic pneumonias, because it mimics infectious pneumonia or acute respiratory distress syndrome in previously healthy individuals. It differs from ICEP by its acute onset, the severity of hypoxemia, the usual lack of increased blood eosinophils at the onset of disease, and the absence of relapse.
Definition
EGPA (formerly, Churg-Strauss syndrome), described in 1951,92 mainly from autopsied cases, is a systemic disease associated with asthma, eosinophilia, and eosinophil-rich and granulomatous inflammation involving the respiratory tract and a small-vessel, necrotizing small to medium-sized vessel necrotizing vasculitis.93 EGPA is associated in approximately 40% of cases with antineutrophil cytoplasmic antibodies (ANCA) and therefore belongs to the pulmonary ANCA-associated vasculitides.
Epidemiology and Risk Factors
EGPA
Epidemiology and Pathogenesis
Allergic bronchopulmonary aspergillosis (ABPA) occurs almost exclusively in subjects with a prior history of chronic bronchial disease. It may occur in up to 1% to 2% of asthmatic adults and in up to 7% to 10% of patients with cystic fibrosis.180, 181 Isolated cases have been reported in patients with chronic obstructive pulmonary disease, and in workers in bagasse-containing sites in sugar-cane mills.182
Chronic bronchial disease is associated with viscid mucus, which with exposure to fungal
Idiopathic Hypereosinophilic Syndromes
The idiopathic hypereosinophilic syndromes, historically defined as a persistent eosinophilia greater than 1500/mm3 for longer than 6 months, without a known cause of eosinophilia, and with presumptive signs and symptoms of organ involvement,220 now encompass 2 variants221, 222: (1) the “lymphocytic variant” (approximately 30% of cases), resulting from clonal Th2 lymphocytes bearing an aberrant antigenic surface phenotype223; and (2) chronic eosinophilic leukemia or the “myeloproliferative
Practical approach to diagnosis and treatment
The diagnosis of eosinophilic lung diseases usually relies primarily on characteristic clinical-imaging features and the demonstration of alveolar eosinophilia, and lung biopsy is generally not necessary. Peripheral blood eosinophilia is an excellent diagnostic biomarker but may be absent at presentation, especially in IAEP and in patients who have already received corticosteroid treatment.
Defining the etiology of eosinophilic lung diseases has practical implications for therapeutic
References (250)
- et al.
Eosinophils and allergic airway disease: there is more to the story
Trends Immunol
(2010) - et al.
Biology of the eosinophil
Adv Immunol
(2009) - et al.
Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome
J Allergy Clin Immunol
(2010) - et al.
Novel targeted therapies for eosinophilic disorders
J Allergy Clin Immunol
(2012) - et al.
Eosinophils and disease pathogenesis
Semin Hematol
(2012) - et al.
Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients
Chest
(1993) Photographic negative shadow of pulmonary oedema
Lancet
(2002)- et al.
Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo
J Allergy Clin Immunol
(1998) - et al.
Chronic eosinophilic pneumonia. Evidence for eosinophil degranulation and release of major basic protein
Am J Med
(1986) - et al.
A clinical study of idiopathic eosinophilic pneumonia
Chest
(1994)
Alterations in smoking habits are associated with acute eosinophilic pneumonia
Chest
A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance
Chest
A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance
Chest
An 18-year-old woman with fever, diffuse pulmonary opacities, and rapid onset of respiratory failure: idiopathic acute eosinophilic pneumonia
Chest
Pneumopathie aiguë à éosinophiles: rôle d'un tabagisme récemment débuté
Rev Mal Resp
Flavored cigar smoking induces acute eosinophilic pneumonia
Chest
A case of acute eosinophilic pneumonia following short-term passive smoking: an evidence of very high level of urinary cotinine
Allergol Int
Eosinophilic alveolitis in acute respiratory failure. A clinical marker for a non-infectious etiology
Chest
Transient wheeze. Eosinophilic bronchobronchiolitis in acute eosinophilic pneumonia
Chest
Acute eosinophilic pneumonia: thin-section CT findings in 29 patients
Eur J Radiol
Circulating thymus- and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury
Chest
Acute eosinophilic pneumonia caused by Candida albicans
Respir Med
Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child
Chest
A case of acute eosinophilic pneumonia with hypersensitivity to “red spider” allergens
J Allergy Clin Immunol
Acute eosinophilic pneumonia in AIDS
Chest
Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists
Am J Med
Familial Churg-Strauss syndrome in two sisters
Chest
Eosinophilic pneumonias
Eosinophilic pneumonias
Allergy
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
J Allergy Clin Immunol
Eosinophilic pneumonia
Eosinophilic pneumonia
Eosinophils: biological properties and role in health and disease
Clin Exp Allergy
The eosinophil
Annu Rev Immunol
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
N Engl J Med
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia
N Engl J Med
Mepolizumab and exacerbations of refractory eosinophilic asthma
N Engl J Med
Eosinophil lung disease: immunological studies of blood and alveolar eosinophils
Clin Exp Immunol
Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia
Thorax
Chronic eosinophilic pneumonia
Thorax
Chronic eosinophilic pneumonia
N Engl J Med
Comparison of registries of interstitial lung diseases in three European countries
Eur Respir J Suppl
Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. The Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P)
Medicine (Baltimore)
Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature
Medicine (Baltimore)
Chronic eosinophilic pneumonia after radiation therapy for breast cancer
Eur Respir J
Chronic eosinophilic pneumonia: an unusual cause of acute respiratory failure
Am Rev Respir Dis
Chronic eosinophilic pneumonia: a cause of adult respiratory distress syndrome
South Med J
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? The Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P)
Eur Respir J
Pneumopathies chroniques à éosinophiles. Etude de 16 cas
Rev Mal Respir
Chronic eosinophilic pneumonia: CT findings in six cases
AJR Am J Roentgenol
Cited by (100)
A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
2024, Respiratory Medicine Case ReportsEosinophilic Lung Diseases
2023, Immunology and Allergy Clinics of North AmericaTwo years follow-up of relapsing eosinophilic pneumonia with concomitant severe asthma successfully treated with benralizumab: A case report and brief review of the literature
2023, Respiratory Medicine Case ReportsCitation Excerpt :ICEP occurs predominantly in patients with high levels of T2 inflammation and two-thirds of patients with ICEP have a prior history of asthma. About 50% of patients have a relapse during tapering or after discontinuation of corticosteroid treatment, increasing the risk of becoming steroid-dependents [2,3]. Given the serious side effects of steroid therapy, other therapies like biotechnological drugs are being explored [4,5].
Treatments of refractory eosinophilic lung diseases with biologics
2023, Allergology InternationalA lepidic adenocarcinoma mimicking an eosinophilic lung
2022, Respiratory Medicine Case ReportsMonoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
2024, BMC Pulmonary Medicine
Conflicts of Interest/Financial Support: Hospices Civils de Lyon, Université Lyon I.